Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Markers Could Predict Risk of Severe Chlamydia Infection

By LabMedica International staff writers
Posted on 15 Aug 2025

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract. More...

Currently, ascension into the uterus and endometrium can only be confirmed through an invasive endometrial biopsy. Researchers have now identified biological markers that may pave the way for new diagnostics to predict a woman’s risk of severe infection without the need for such procedures.

A collaborative team from North Carolina State University (Raleigh, NC, USA) and the UNC School of Medicine (Chapel Hill, NC, USA) analyzed cervicovaginal microbiome (CVM) samples from 246 women in a high-risk cohort for chlamydia. Using 16S ribosomal RNA (rRNA) gene-based high-throughput amplicon sequencing, they tagged and quantified bacteria present in the samples. Participants were classified into three groups—CT negative, CT positive, and CT ascended—to assess differences in microbiome composition.

The sequencing analysis revealed that higher amounts of certain bacterial species, such as Hemophilus haemolyticus, Sutterella stercoricanis, and Actinobaculum massiliense, were predictive of ascended infections. These microbes also correlated with seven cytokines previously linked to chlamydia spread. Notably, the study found that the bacterial load of chlamydia itself was the strongest predictor of ascension.

The findings, published in Infection and Immunity, indicate that specific microbial and immune profiles could be developed into biomarkers to identify women at high risk for upper genital tract infection. Such diagnostics could enable earlier intervention, potentially preventing severe reproductive outcomes. Future studies will focus on understanding how these microbes influence immune responses to control chlamydia levels and disease progression.

"We knew that some bacterial species make a woman more susceptible to CT infection, while ‘good’ bacteria such as lactobacillus seem to make it harder to become infected," said Catherine O’Connell, professor of pediatrics, UNC School of Medicine, and co-project leader. “This work shows that other bacteria present may be keeping host immunity alert and responsive, making it harder for infecting chlamydia to grow abundantly. It shows that there is potential for developing biomarkers to identify women at high risk for ascended CT.”


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Collection and Transport System
PurSafe Plus®
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LungCanSeek demonstrated an overall sensitivity of 83.5% and specificity of 90.3% in detecting lung cancer (Photo courtesy of AdobeStock)

New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

Lung cancer remains the leading cause of cancer-related deaths worldwide, largely because most cases are diagnosed at advanced stages when treatment options are limited. Early detection significantly improves... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The TriVerity IVD test includes the TriVerity cartridge and the Myrna instrument (Photo courtesy of Inflammatix)

Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients

When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.